Single-Anastomosis Sleeve Jejunal Bypass, a Novel Bariatric Surgery, Versus Other Familiar Methods: Results of a 6-Month Follow-up-a Comparative Study.
Bariatric surgery
Body mass index
Jejunal bypass
Metabolic surgery
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
27
11
2019
medline:
15
4
2021
entrez:
27
11
2019
Statut:
ppublish
Résumé
Obesity and its associated morbidities have become a significant concern all over the world. Bariatric surgery, regardless of its type, is the most effective approach for treating morbid obesity. Single-anastomosis sleeve jejunal (SASJ) bypass is a novel bariatric surgery technique and can be considered for patients with former background of severe gastroesophageal symptoms. The purpose of this research was to compare SASJ bypass outcomes with other techniques during a 6-month follow-up. This is a non-randomized clinical trial conducted on 100 patients, who underwent four types of bariatric surgery (classic Roux-en-Y bypass, SASJ bypass, omega gastric bypass, and sleeve gastrectomy), and each one of these types contained 25 cases, during the time period of 2 years from 2016 to 2018. Patients' information including age, gender, height, basal weight, body mass index (BMI), serum albumin, and hemoglobin A1C were recorded, within 1, 3, and 6 months after their surgery, and also were compared with each other. Members of the four groups were similar due to their age, gender distribution, height, baseline BMI, hemoglobin A1C, albumin, and also excess weight (P value > 0.05); however, the sleeve gastrectomy group baseline weight was significantly higher compared with the other three groups (P value = 0.013). All of the groups significantly lost weight during this 6-month period, but the comparison between them indicated no statistical difference regarding excess weight loss, BMI, hemoglobin A1C, and albumin (P value > 0.05). The excess weight loss mean during 6 months in SASJ bypass was 34.2 ± 5.4%, which was comparable with other groups. The weight loss trend after the SASJ bypass was similar to that of older techniques; consequently this technique can be considered for cases with particular indications due to the reversibility and also more accessible gastric follow-up studies in the SASJ approach. Further researches with longer follow-ups are strongly recommended.
Sections du résumé
BACKGROUND
Obesity and its associated morbidities have become a significant concern all over the world. Bariatric surgery, regardless of its type, is the most effective approach for treating morbid obesity. Single-anastomosis sleeve jejunal (SASJ) bypass is a novel bariatric surgery technique and can be considered for patients with former background of severe gastroesophageal symptoms. The purpose of this research was to compare SASJ bypass outcomes with other techniques during a 6-month follow-up.
METHODS
This is a non-randomized clinical trial conducted on 100 patients, who underwent four types of bariatric surgery (classic Roux-en-Y bypass, SASJ bypass, omega gastric bypass, and sleeve gastrectomy), and each one of these types contained 25 cases, during the time period of 2 years from 2016 to 2018. Patients' information including age, gender, height, basal weight, body mass index (BMI), serum albumin, and hemoglobin A1C were recorded, within 1, 3, and 6 months after their surgery, and also were compared with each other.
RESULTS
Members of the four groups were similar due to their age, gender distribution, height, baseline BMI, hemoglobin A1C, albumin, and also excess weight (P value > 0.05); however, the sleeve gastrectomy group baseline weight was significantly higher compared with the other three groups (P value = 0.013). All of the groups significantly lost weight during this 6-month period, but the comparison between them indicated no statistical difference regarding excess weight loss, BMI, hemoglobin A1C, and albumin (P value > 0.05). The excess weight loss mean during 6 months in SASJ bypass was 34.2 ± 5.4%, which was comparable with other groups.
CONCLUSIONS
The weight loss trend after the SASJ bypass was similar to that of older techniques; consequently this technique can be considered for cases with particular indications due to the reversibility and also more accessible gastric follow-up studies in the SASJ approach. Further researches with longer follow-ups are strongly recommended.
Identifiants
pubmed: 31768867
doi: 10.1007/s11695-019-04266-9
pii: 10.1007/s11695-019-04266-9
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
769-776Références
Obes Surg. 2019 Nov;29(11):3769-3770
pubmed: 31254211
Obes Surg. 2009 Oct;19(10):1341-5
pubmed: 19626382
J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S89-96
pubmed: 18987275
Surg Obes Relat Dis. 2008 Mar-Apr;4(2):166-72; discussion 172-3
pubmed: 18069071
Obes Surg. 2000 Jun;10(3):233-9
pubmed: 10929154
Obes Surg. 2008 Jan;18(1):17-26
pubmed: 18080721
Obes Surg. 2006 Sep;16(9):1261-3; author reply 1263-4
pubmed: 16989717
Endocrinol Metab Clin North Am. 2001 Sep;30(3):765-85
pubmed: 11571940
J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S16-29
pubmed: 19801361
Int J Surg. 2016 Oct;34:28-34
pubmed: 27545956
JAMA. 2014 Sep 3;312(9):959-61
pubmed: 25182106
Obes Surg. 2015 Oct;25(10):1822-32
pubmed: 25835983
Cochrane Database Syst Rev. 2014 Aug 08;(8):CD003641
pubmed: 25105982
Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1092-8
pubmed: 26048517
Obes Surg. 2012 Jul;22(7):1104-9
pubmed: 22527590
Ann Surg. 2013 Jan;257(1):87-94
pubmed: 23235396
Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):160-169
pubmed: 27899816
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):765-70
pubmed: 25813754
Dig Dis Sci. 1995 May;40(5):1074-82
pubmed: 7729267
N Engl J Med. 2013 Oct 10;369(15):1434-42
pubmed: 24106936
Obes Surg. 2003 Apr;13(2):159-60
pubmed: 12760387
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv
pubmed: 19726018
Obes Surg. 2016 May;26(5):926-32
pubmed: 26337694
Int J Obes Relat Metab Disord. 2001 Dec;25 Suppl 5:S42-7
pubmed: 11840214
Obes Surg. 2016 Dec;26(12):2862-2872
pubmed: 27138599
Obes Surg. 2010 Jun;20(6):776-90
pubmed: 20333558
Obes Surg. 2006 Mar;16(3):353-8
pubmed: 16545168
Obes Surg. 2012 Jul;22(7):1097-103
pubmed: 22527596
Obes Surg. 2006 Oct;16(10):1323-6
pubmed: 17059741